In NSCLC patients, the phenotyping of CD161+ T cells identified a higher frequency of CD161-expressing CD4+ T cells infiltrating the tumor compared to distant lung, draining lymph node and blood (54). This evidence concerns the gene CD4 and non-small cell lung carcinoma.